| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/17/2007 | US7205274 Hybrid peptides modulate the immune response |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205127 Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase |
| 04/17/2007 | US7205120 Detection Alzheimer's disease |
| 04/17/2007 | US7205108 Trp8, Trp9 and Trp10, novel markers for cancer |
| 04/17/2007 | US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | US7205000 Use of slurry in hemo and peritoneal dialysis applications |
| 04/17/2007 | US7204996 Method of cancer treatment |
| 04/17/2007 | US7204980 Methods for inhibiting viral replication in vivo |
| 04/17/2007 | US7204978 Treatment and diagnosis of infertility using TGFβ or activin |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2320731C Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 04/17/2007 | CA2283648C Polymeric carrier |
| 04/17/2007 | CA2182417C Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 04/14/2007 | CA2564064A1 Genetic variations associated with psychiatric disorders |
| 04/14/2007 | CA2524551A1 Use of selenium yeasts in the treatment of alzheimer's disease |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040128A1 Therapeutic agent for heart failure |
| 04/12/2007 | WO2007039760A2 Use of oligouronates for treating mucus hyperviscosity |
| 04/12/2007 | WO2007039754A1 Use of oligouronates for treating mucus hyperviscosity |
| 04/12/2007 | WO2007016385A3 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 04/12/2007 | WO2007011843A3 Prevention and treatment of ophthalmic complications of diabetes |
| 04/12/2007 | WO2006116221A3 Therapeutic combinations for the treatment or prevention of psychotic disorders |
| 04/12/2007 | WO2006115800A3 Enhanced wound healing utilizing an anti-her2 antibody coupled to a tnf alpha |
| 04/12/2007 | WO2005011594A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 04/12/2007 | WO2002086079A3 T1r3 a novel taste receptor |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082955 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
| 04/12/2007 | US20070082942 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft |
| 04/12/2007 | US20070082938 Polymorphs of bicifadine hydrochloride |
| 04/12/2007 | US20070082937 Anti cancer combinations comprising a cox-2 inhibitor |
| 04/12/2007 | US20070082930 Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug |
| 04/12/2007 | US20070082883 HIV protease inhibitors |
| 04/12/2007 | US20070082873 Combinations comprising ampa receptor antagonists for the treatment of schizophrenia |
| 04/12/2007 | US20070082863 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 04/12/2007 | US20070082856 Combination therapy comprising the use of et-743 and doxorubicin for treating cancer |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070081979 Multi-functional chimeric hematopoietic receptor agonists |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | CA2624568A1 Oligouronate treatment |
| 04/12/2007 | CA2624088A1 Sustained release small molecule drug formulation |
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1772152A2 Composition for inducing immunotolerance |
| 04/11/2007 | EP1772145A1 Method of effectively using medicine and method concerning prevention of side effect |
| 04/11/2007 | EP1771551A2 Novel cell populations and uses thereof |
| 04/11/2007 | EP1771200A1 Physiologically-active composition based on collagen |
| 04/11/2007 | EP1771197A2 Pegylated interferon alpha-1b |
| 04/11/2007 | EP1771179A2 COMPOSITIONS COMPRISING 5-ALPHA REDUCTASE INHIBITORS, AND SERMs AND METHODS OF USE THEREOF |
| 04/11/2007 | EP1771162A2 Capsaicin inhibitors for treating obesity and related disorders |
| 04/11/2007 | EP1589834B1 Enteral composition for the prevention and/or treatment of sepsis |
| 04/11/2007 | EP1567163B1 Method of treating nausea, vomiting, retching or any combination thereof |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1490093A4 Methods and compositions for the treatment of ischemia |
| 04/11/2007 | EP1435985B1 Medicament containing activated antithrombin iii |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 04/11/2007 | EP1272177B1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 04/11/2007 | EP1267850B1 Use of insulin sensitivity increasing substances for the treatment of alopecia |
| 04/11/2007 | EP1221861B1 Fat or oil composition |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP1019044B1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 04/11/2007 | EP0961780B1 Protein markers for lung cancer and use thereof |
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | CN1946717A Benzimidazole derivative and its use |
| 04/11/2007 | CN1946456A Alcohol metabolism moderating composition |
| 04/11/2007 | CN1946424A Treatment of fungal infections |
| 04/11/2007 | CN1946411A Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination |
| 04/11/2007 | CN1946409A Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 04/11/2007 | CN1946404A Pharmaceutical compositions for the treatment of sexual disorders II |
| 04/11/2007 | CN1946391A Combinations comprising alpha-2-delta ligands |
| 04/11/2007 | CN1943790A Prevention and treatment of restenosis by local administration of drug |
| 04/11/2007 | CN1943786A Ester compound and its medicinal application |
| 04/11/2007 | CN1943785A A suspension used for treatment of hepatic transplantation rejection |
| 04/11/2007 | CN1943771A The pharmaceutical for treatment of vascular lesion through actions on the NEI network |
| 04/11/2007 | CN1943565A Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method |
| 04/11/2007 | CN1943558A Lipid nano particles containing amphiphilic polymer and its preparing method |
| 04/11/2007 | CN1943525A Method for improving ox and sheep freezing sperm fertility rate and its dilute liquid used thereof |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309741C Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 04/11/2007 | CN1309735C Soluble CTL A4 mutant molecules and use thereof |
| 04/11/2007 | CN1309421C Antineoplastic combinations of such as rapamycin and gemcitabine or fluorouracil |
| 04/11/2007 | CN1309390C Medicine for lung cnncer |
| 04/11/2007 | CN1309377C Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | US7202347 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202235 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for controlling Cryptosporidium parvum disorders such as diarrhea, particularly in immunodeficient individuals |
| 04/10/2007 | US7202231 β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/10/2007 | US7202058 IGF-1 receptor interacting proteins |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
| 04/10/2007 | US7201924 an aqueous Soma, comprising apple cider vinegar, quinine, blackstrap molasses, sulfur, and whole milk; suited for treating lymphoid malignancies |
| 04/10/2007 | US7201917 Particles suspended in matrix |